Antibiotic-resistant bacteria are increasingly the source of deadly infections. Scientists have now modified an approved cancer drug to develop an active agent against multidrug-resistant pathogens.
from Top Health News -- ScienceDaily https://ift.tt/2McTN2D
Post a Comment